Skip to content
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Hepatology

What is the ELF Test for Primary Biliary Cholangitis?

At a Glance

The Enhanced Liver Fibrosis (ELF) test is a non-invasive blood test that measures how actively the liver is forming new scar tissue. For patients with Primary Biliary Cholangitis (PBC), it helps doctors predict long-term liver health without a biopsy.

The Enhanced Liver Fibrosis (ELF) score is a specialized blood test that measures the active process of liver scarring, known as fibrogenesis [1]. If your doctor has ordered an ELF test for your Primary Biliary Cholangitis (PBC), they are looking for specific biological markers in your blood that indicate how actively your liver is producing scar tissue [2].

While this test might seem similar to other lab work you have had done, it serves a distinct and vital role in predicting your long-term liver health without the need for an invasive liver biopsy [3].

How is the ELF Test Different from Other Tests?

Your care team uses different tests together to get a complete picture of your liver health. The ELF test does not replace your standard labs; rather, it adds a new layer of critical information [4].

  • Regular Liver Panel: A standard liver panel measures enzymes and proteins—like alkaline phosphatase (ALP) and bilirubin [5]. These standard tests are excellent for showing active liver inflammation and how well your liver is currently performing its normal jobs. However, they do not directly measure scarring.
  • FibroScan: A FibroScan (elastography) works like an ultrasound, measuring the physical stiffness of your liver [6]. It takes a snapshot of the scar tissue that has already formed.
  • The ELF Test: Unlike standard panels or a FibroScan, the ELF test specifically looks for the proteins involved in building scar tissue [7]. It measures the biological activity of scarring happening right now [8].

Doctors often use the ELF test and FibroScan together because they provide complementary information: the FibroScan shows how much scarring already exists, while the ELF score suggests how actively new scarring is forming [4].

What Specific Markers Does the ELF Test Measure?

The ELF score is calculated using an algorithm that combines the levels of three specific biomarkers found in your blood [1]:

  1. Hyaluronic Acid (HA)
  2. Procollagen III N-terminal peptide (PIIINP)
  3. Tissue inhibitor of metalloproteinase 1 (TIMP-1)

These three markers are direct byproducts of matrix remodeling—the way your liver tries to rebuild itself after damage. When liver damage from PBC goes on for too long, this rebuilding process can lead to excess fibrosis (scarring) [9].

Understanding Your Score and Results

When you see your results in your patient portal, the ELF test will be reported as a single number (often ranging between 7 and 11 or higher). The key thing to know is that higher scores indicate a higher risk of active, advanced scarring, while lower scores suggest less active scar formation [10].

Because the markers measured in the ELF test (HA, PIIINP, TIMP-1) are found throughout the body, your score can sometimes be influenced by age or other health conditions that cause inflammation or systemic scarring—such as severe rheumatoid arthritis or certain lung diseases. Your doctor will interpret your specific number in the context of your overall health [8].

Why is the ELF Score Important in PBC?

For patients with PBC, the ELF test offers several important benefits for long-term care:

  • Identifying Advanced Fibrosis Non-Invasively: The test has high diagnostic accuracy for identifying severe or advanced fibrosis, helping you and your doctor evaluate liver health without needing a biopsy [11].
  • Predicting Long-Term Outcomes: Research shows that the ELF score is a powerful tool for predicting long-term outcomes, such as the risk of liver-related complications [3]. It has been shown to outperform simpler blood tests (like the FIB-4 score) in evaluating disease prognosis [12].
  • Tracking Disease Progress: Your doctor can order the ELF test repeatedly during routine follow-ups (for example, once a year) to track whether your liver scarring is progressing or if your PBC treatments are helping to slow it down [13].

Note on lab logistics: Check with your doctor or lab beforehand to see if you need to fast, as clinic policies can vary. Additionally, the accuracy of the ELF test can be affected by routine blood-draw issues. For example, if red blood cells accidentally break during the draw (a common occurrence called hemolysis), it can falsely alter the score [14]. If your doctor asks for a redraw, don’t panic—it is often just due to this simple lab handling issue rather than a sign that your disease is worsening.

Common questions in this guide

What does the Enhanced Liver Fibrosis (ELF) test measure?
The ELF test is a specialized blood test that measures the active process of liver scarring, also known as fibrogenesis. It looks for three specific biological markers in your blood that indicate how actively your liver is producing new scar tissue.
How is the ELF test different from a FibroScan?
A FibroScan works like an ultrasound to measure the physical stiffness of your liver and shows existing scar tissue. The ELF test is a blood test that measures the biological activity of new scar tissue that is currently forming.
What does a high ELF score mean?
A higher ELF score generally indicates a higher risk of active, advanced liver scarring. Your doctor will evaluate your specific number alongside other tests to understand your long-term liver health.
Can other health conditions affect my ELF test results?
Yes, conditions that cause systemic inflammation or scarring, such as severe rheumatoid arthritis or certain lung diseases, can influence your ELF score. This is because the markers measured by the test can be found throughout the body, not just in the liver.
Why might my doctor ask for an ELF test redraw?
If red blood cells accidentally break during a routine blood draw, it can falsely alter your ELF score. If your doctor asks for a redraw, it is often just a simple lab handling issue and not a sign that your liver disease is worsening.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How does my current ELF score compare to my previous results, and what does the trend tell us?
  2. 2.Do you recommend combining my ELF blood test with a FibroScan to get a better picture of my liver?
  3. 3.Considering my other health conditions (like arthritis), could they be influencing my ELF score?
  4. 4.How often should we be repeating the ELF test to monitor my PBC?
  5. 5.Does this result mean we need to adjust or add to my current PBC medications?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    Investigation of Serum Markers of Hepatic Fibrosis in Equids.

    Potier JFN, Durham AE, Modi R, et al.

    Journal of equine veterinary science 2023; (131()):104937 doi:10.1016/j.jevs.2023.104937.

    PMID: 37816414
  2. 2

    Accuracy of the Enhanced Liver Fibrosis test, and combination of the Enhanced Liver Fibrosis and non-invasive tests for the diagnosis of advanced liver fibrosis in patients with non-alcoholic fatty liver disease.

    Inadomi C, Takahashi H, Ogawa Y, et al.

    Hepatology research : the official journal of the Japan Society of Hepatology 2020; (50(6)):682-692 doi:10.1111/hepr.13495.

    PMID: 32090397
  3. 3

    MRE and ELF in Liver Fibrosis Assessment: Are Two Better Than One?

    Tien PC, Duarte M, Roque A, Price J

    Digestive diseases and sciences 2020; (65(4)):928-930 doi:10.1007/s10620-019-05923-w.

    PMID: 31828462
  4. 4

    A Pragmatic Approach Identifies a High Rate of Nonalcoholic Fatty Liver Disease With Advanced Fibrosis in Diabetes Clinics and At-Risk Populations in Primary Care.

    Patel P, Hossain F, Horsfall LU, et al.

    Hepatology communications 2018; (2(8)):893-905 doi:10.1002/hep4.1208.

    PMID: 30094401
  5. 5

    Novel noninvasive indices for the assessment of liver fibrosis in primary biliary cholangitis.

    Li Y, Zhang MJ, Wang XH, Li SH

    Biomedical reports 2024; (20(1)):1 doi:10.3892/br.2023.1689.

    PMID: 38222865
  6. 6

    Systematic review and meta-analysis: Transient elastography compared to liver biopsy for staging of liver fibrosis in primary biliary cholangitis.

    Manzo-Francisco LA, Aquino-Matus J, Vidaña-Pérez D, et al.

    Annals of hepatology 2023; (28(4)):101107 doi:10.1016/j.aohep.2023.101107.

    PMID: 37088420
  7. 7

    Non-invasive detection of portal hypertension by enhanced liver fibrosis score in patients with different aetiologies of advanced chronic liver disease.

    Simbrunner B, Marculescu R, Scheiner B, et al.

    Liver international : official journal of the International Association for the Study of the Liver 2020; (40(7)):1713-1724 doi:10.1111/liv.14498.

    PMID: 32358998
  8. 8

    Noninvasive evaluation of fibrosis in adult biliary diseases.

    Helgadottir H, Vesterhus M

    Current opinion in gastroenterology 2023; (39(2)):83-88 doi:10.1097/MOG.0000000000000909.

    PMID: 36821455
  9. 9

    Diagnostic Accuracy of the Enhanced Liver Fibrosis (ELF®) Score Using HCV-Infected Serum Samples Cryopreserved for up to 25 Years.

    Puigvehí M, Hernández J, Broquetas T, et al.

    PloS one 2016; (11(12)):e0164883 doi:10.1371/journal.pone.0164883.

    PMID: 27984583
  10. 10

    Accuracy of the Enhanced Liver Fibrosis Test in Patients With Type 2 Diabetes Mellitus and Its Clinical Implications.

    Arai T, Takahashi H, Seko Y, et al.

    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2024; (22(4)):789-797.e8 doi:10.1016/j.cgh.2023.11.022.

    PMID: 38048934
  11. 11

    Enhanced liver fibrosis score as a surrogate of liver-related complications and mortality in primary biliary cholangitis.

    Fujinaga Y, Namisaki T, Takaya H, et al.

    Medicine 2021; (100(39)):e27403 doi:10.1097/MD.0000000000027403.

    PMID: 34596167
  12. 12

    Noninvasive Methods for Assessing Liver Fibrosis and Steatosis.

    Kazi IN, Kuo L, Tsai E

    Gastroenterology & hepatology 2024; (20(1)):21-29.

    PMID: 38405045
  13. 13

    Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents.

    Cossiga V, La Civita E, Bruzzese D, et al.

    Frontiers in pharmacology 2022; (13()):891398 doi:10.3389/fphar.2022.891398.

    PMID: 36059971
  14. 14

    Preanalytical factors of enhanced liver fibrosis (ELF™) laboratory testing: the score is affected by hemolysis.

    Kelkka A, Pussinen C, Joutsi-Korhonen L, et al.

    Scandinavian journal of clinical and laboratory investigation 2025; (85(5)):379-386 doi:10.1080/00365513.2025.2546316.

    PMID: 40838567

This page explains the Enhanced Liver Fibrosis (ELF) test for educational purposes only and does not constitute medical advice. Always consult your hepatologist or primary care provider to interpret your specific lab results.

Get notified when new evidence is published on Primary biliary cholangitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.